On February 1st, President Trump issued an Executive Order, “Imposing Duties to Address the Synthetic Opioid Supply Chain from the People’s Republic of China.” Today, the President issued an “Amendment” to the Executive Order, effectively reinstating Sec. 321 de minimis treatment for China and Hong Kong products.  Listen to today's Two Minutes in Trade to keep up with this ever-changing trade news.   

 

Listen to our Podcast

Copyright © 2025 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.

Professional

avatar
Mark J. Segrist
Partner, Advisory Committee
Close

Cookie Consent

We have updated our Privacy Policy relating to our use of cookies on our website and the sharing of information. By continuing to use our website or subscribe to our publications, you agree to the Privacy Policy and Terms & Conditions.